The company’s shares are trading ex-dividend on Wednesday.
The post Why is the Fisher & Paykel share price heading south today? appeared first on The Motley Fool Australia. –
TheÂ Fisher & Paykel Healthcare Corp LtdÂ (ASX: FPH) share price is sliding in early trade today.
At the time of writing, the medical device companyâs shares are down 1.64% to $17.43.
On the other hand, theÂ S&P/ASX 200 IndexÂ (ASX: XJO) is edging higher. The benchmark ASX 200 Index is currently up 0.13% to 6,532 points.
Let’s check what’s going on with the New Zealand-based company.
Shareholders secure the Fisher & Paykel Healthcare final dividend
With the companyâs full-year earning seasons wrapped up, Fisher & Paykel Healthcare shares are trading ex-dividendÂ today.
This comes after the company released its FY22 results on 25 May, reporting mixed numbers across key financial metrics.
Nonetheless, the board opted to slightly increase its final dividend by 2% over the prior corresponding period.
This brings the company’s full-year dividend to 39.5 cents, an improvement of 4% from FY21.
Typically, one business day before the record date, the ex-dividend date, is when investors must have purchased shares. If the investor didnât buy Fisher & Paykel Healthcare shares before this date, the dividend will go to the seller.
When can shareholders expect to be paid?
For those eligible for Fisher & Paykel Healthcareâs final dividend, shareholders will receive a payment of NZ$0.22.5 cents (A$0.2046) per share on 6 July. The dividend is unfranked which means investors wonât get any tax credits from this.
Under the company’sÂ capital management framework, managementâs priority is to appropriately invest in the business to support long-term sustainable growth.
The company has a âtarget debt to debt plus equity ratio in the range of +5% to -5%â. This also takes into account future business performance and cash requirements to run its operations.
In addition, Fisher & Paykel Healthcare has a trailing dividend yield of 2.2%.
Fisher & Paykel Healthcare share price snapshot
Since the beginning of 2022, the Fisher & Paykel Healthcare share price has tumbled more than 40%.
Notably, the companyâs shares reached a 52-week low of $17.14 last week on the back of weakened sentiment.
Based on todayâs price, Fisher & Paykel Healthcare presides aÂ market capitalisationÂ of approximately $10 billion.
The post Why is the Fisher & Paykel share price heading south today? appeared first on The Motley Fool Australia.
Before you consider Fisher & Paykel Healthcare Corp Ltd, you’ll want to hear this.
Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Fisher & Paykel Healthcare Corp Ltd wasn’t one of them.
The online investing service heâs run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.
See The 5 Stocks
*Returns as of January 13th 2022
setButtonColorDefaults(“#43B02A”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#43B02A”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
5 things to watch on the ASX 200 on Wednesday
How does the Macquarie dividend stack up against the ASX big four banks?
Here are the 3 most heavily traded ASX 200 shares on Tuesday
How to start investing in stocks: This ASX 200 share is where Iâd begin
The ANZ share price has tumbled 24% from its 2022 high. Is it time to pounce?
Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.